MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1111/ene.15292

Медицинская библиотека · European journal of neurology · 2022

Association of immunosuppression treatment with generalization among patients with ocular myasthenia gravis: A propensity score analysis.

Ruan Zhe, Guo Rongjing, Zhou Hongyu, Gao Feng, Lin Ye, Xu Quan, Yu Liping, Wu Songdi, Lei Tao, Zhang Min, Gao Yanwu, Lu Xiaodan, Li Huanhuan, Sun Chao, Tang Baoli, Li Zhuyi, Chang Ting

СтатьяПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

BACKGROUND

To analyze disease generalization in patients with ocular myasthenia gravis (OMG) treated with immunosuppression compared with patients without immunosuppression treatment.

METHODS

In this retrospective cohort study, we analyzed data from patients with OMG at seven medical centers in China from January 1, 2015 to May 1, 2019 and compared disease generalization in patients (treated with immunosuppression vs. not treated) within 2 years of disease onset using raw and inverse probability of treatment weighting (IPTW) analyses.

RESULTS

In the study population of 813 patients with OMG, 425 (52.3%) with immunosuppression had a mean (SD) onset age of 50.0 (15.1) years, and 188 (44.2%) were women. The remaining 388 (47.7%) patients were not immunosuppressed (mean age, 48.4 [15.0] years; 185 [47.7%] women). Disease generalization developed in 122 (31.4%) and 37 (8.7%) patients in the non-immunosuppression and immunosuppression groups, respectively. Relative to non-immunosuppression, immunosuppression was associated with a lower risk of generalization in a multivariable-adjusted Cox model (hazard ratio [HR] 0.27; 95% confidence interval [CI] 0.18-0.40; p < 0.001) and IPTW-weighted Cox model (HR 0.28; 95% CI 0.19-0.42; p < 0.001). In sensitivity analyses, longer duration of immunosuppression was associated with a lower risk of generalization (HR 0.90 for every 1-month increase; 95% CI 0.87-0.92; p < 0.001; IPTW-adjusted). Combination therapy with steroids and non-steroidal immunosuppressants showed superior efficacy in reducing the risk of generalization (HR 0.14; 95% CI 0.07-0.26; p < 0.001).

CONCLUSION

Immunosuppression significantly reduced the 2-year risk of generalization in patients with OMG.

Для цитирования: Ruan Zhe, Guo Rongjing, Zhou Hongyu, Gao Feng, Lin Ye, Xu Quan, Yu Liping, Wu Songdi, Lei Tao, Zhang Min, Gao Yanwu, Lu Xiaodan, Li Huanhuan, Sun Chao, Tang Baoli, Li Zhuyi, Chang Ting. Association of immunosuppression treatment with generalization among patients with ocular myasthenia gravis: A propensity score analysis.. European journal of neurology. 2022. DOI: 10.1111/ene.15292.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.